PROTECTION-II: Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A 100kV Protocol

Sponsor
Deutsches Herzzentrum Muenchen (Other)
Overall Status
Unknown status
CT.gov ID
NCT00611780
Collaborator
(none)
400
1
2
12
33.3

Study Details

Study Description

Brief Summary

The objective of this study is to compare radiation dose of a 100kV scan protocol to the standard 120kV scan protocol. We hypothesize that the 100kV scan protocol is associated with a reduction in dose estimates of at least 20%, while the diagnostic image quality is not inferior.

Secondary endpoints of the study include quantitative image quality parameters, diagnostic accuracy for 120 vs.100kV studies compared to invasive angiography in patients who underwent subsequent invasive coronary angiography

Condition or Disease Intervention/Treatment Phase
  • Radiation: tube voltage
  • Radiation: tube voltage
Phase 4

Detailed Description

All patients scheduled for a coronary CT scan are screened for inclusion and exclusion criteria. Patients are included if they have stable sinus rhythm (heart rate <100 bpm) and a body weight < 90 kg or a body mass index (BMI) < 30. Informed signed consent is obtained from these patients and the CT scan is prepared. After topogram scan and the native scan for Ca-Scoring, patients are randomized in two groups with the use of sealed envelopes. After that contrast-enhanced coronary CT angiography is performed with the 120kV- or 100kV-protocol.

The CT examination is evaluated by two experienced investigators on a per-vessel basis and all results and study-related data are collected in a dedicated database. For assessment of image quality, a previously established 4-point score system is used and quantitative image quality parameters are measured.

A 30 day follow-up after the CT examination aims to evaluate if patients underwent invasive coronary angiography or were scheduled for a myocardial stress / perfusion test (such as stress-echocardiography, myocardial scintigraphy or stress perfusion imaging by MRI).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A 100kV Protocol
Study Start Date :
Jan 1, 2008
Anticipated Primary Completion Date :
Dec 1, 2008
Anticipated Study Completion Date :
Jan 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Reduced tube voltage of 100kV.

Radiation: tube voltage
reduced voltage of 100 kV

Active Comparator: 2

Standard tube voltage of 120kV.

Radiation: tube voltage
standard 120 kV

Outcome Measures

Primary Outcome Measures

  1. Compared with a 120kV protocol the use of a 100kV scan protocol is associated with a reduction in dose estimates of at least 20%, while the diagnostic image quality is not inferior. [30 days]

Secondary Outcome Measures

  1. impact of the 100kV scan protocol on quantitative image quality parameters, e.g. image noise, signal and contrast intensity, signal- and contrast-to-noise-ratios [30 days]

  2. diagnostic accuracy (sensitivity, specificity as well as positive and negative predictive values) for 120kV vs. 100 kV studies when compared with invasive coronary angiography on a per-vessel based analysis. [30 days]

  3. frequency of non-diagnostic CTA studies when comparing 120kV and 100kV [30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with an indication for a coronary CT angiography (planned evaluation of the coronary arteries)

  • stable sinus rhythm

  • patient weight < 90kg or body mass index < 30 kg/m2

  • signed informed consent

Exclusion Criteria:
  • non-ECG triggered studies

  • non-coronary CTA studies, e.g. bypass graft CTAs, pre- or post EP studies, CABG planning studies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Deutsches Herzzentrum Muenchen Munich Germany 80636

Sponsors and Collaborators

  • Deutsches Herzzentrum Muenchen

Investigators

  • Principal Investigator: Joerg Hausleiter, MD, Deutsches Herzzentrum Muenchen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00611780
Other Study ID Numbers:
  • GE IDE No. R00207
First Posted:
Feb 11, 2008
Last Update Posted:
Aug 27, 2008
Last Verified:
Aug 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 27, 2008